Sept. 14, 2009 – Abbott said today the Chinese State Food and Drug Administration (SFDA) has approved the XIENCE V ...
September 11, 2009 – Abbott said yesterday it reached an $410 million agreement to purchase Evalve Inc., the global ...
The HI-TORQUE Balance Middle Weight (BMW) Universal II Guide Wire offers the same performance of Abbott’s HT BMW ...
The Perclose ProGlide 6 Fr. Suture-Mediated Closure System delivers a secure, reliable vessel closure to provide ...
The HI-TORQUE Versacore .035 Guide Wire is a peripheral guide wire is designed for routine diagnostic and device ...
The FoxCross PTA Catheter is a next-generation .035 balloon dilatation catheter is used to open peripheral arteries that ...
September 3, 2009 – Abbott said last week it received approval from Health Canada for the XIENCE V Everolimus-Eluting ...
September 2, 2009 – Abbott announced Monday at the European Society of Cardiology Congress the widespread availability ...
August 13, 2009 – Abbott today announced the expansion of the company's XIENCE V USA post-approval study designed to ...
August 13, 2009 – The pharmaceutical and healthcare research firm Decision Resources found Merck/Schering-Plough's Zetia ...